Skip to Main Content

Paper Details

Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.
Mol Cancer Ther
29
2012
Author NameAffiliation
Colin C CollinsUniversity of British Columbia
  • 1 - 1

Datasets

Release 1.2